Hinge Health is a health information service company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker HNGE on the NYSE exchange.
Hinge Health stock last closed at $56.08, down 2.86% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Health Information Services industry by N/A percentage points. Hinge Health stock is currently +67.79% from its 52-week low of $33.42, and -9.78% from its 52-week high of $62.16.
At the moment, there are 78.44M HNGE shares outstanding. The market capitalization of HNGE is $4.40B. In the last 24 hours, 480,000 HNGE shares were traded.
You need a brokerage account to access the NYSE market and buy HNGE shares.
In our opinion, eToro is the best brokerage. eToro gives you:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, you need to fill out some personal details so you are able to buy HNGE today.
Now that you have opened your account on the greatest app to buy stocks, you can securely and quickly fund your account:
Check out the video below for more details depositing funds into your investment account.
After you have chosen the best place to buy Hinge Health stock, it's very important to analyze their stock prior to investing, so you actually comprehend the risk and upside.
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on HNGE's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge HNGE's fair value.
Using relative valuations ratios:
You can access more valuation research on HNGE's stock here.
Out of 13 sell side analysts who give ratings on HNGE, the consensus analyst rating on Hinge Health is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Brad Sills, a top 5% analyst from Bank of America maintains HNGE with a strong buy rating and raises their HNGE price target from $42.00 to $64.00, on Aug 6, 2025.
Craig Hettenbach, a top 24% analyst from Morgan Stanley maintains HNGE with a strong buy rating and raises their HNGE price target from $46.00 to $57.00, on Aug 6, 2025.
Morgan Stanley's Craig Hettenbach raised their price target on Hinge Health (NYSE: HNGE) by 23.9% from $46 to $57 on 2025/08/06. The analyst maintained their Strong Buy rating on the stock.
Hinge Health reported its Q2 2025 earnings.
Hettenbach said regarding the quarter that revenue growth and the forward trajectory cleared "high bars" with a "solid beat and raise."
Looking ahead, the analyst told readers that assessing the print, Morgan Stanley increased its annual revenue estimates by 8% and its EBIT estimates by "more than double" for 2025 because the company "delivered exceptional incremental margins."
For Q2 2025, Hinge Health reported:
Management guided:
For Q3 2025:
For FY 2025:
CEO Daniel Perez commented: "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform.
"The journey of automating healthcare delivery will be challenging, but we’re excited about our momentum and are moving with haste to capture this opportunity."
David Grossman, a top 13% analyst from Stifel Nicolaus maintains HNGE with a strong buy rating and raises their HNGE price target from $48.00 to $55.00, on Aug 1, 2025.
Scott Schoenhaus, a bottom 4% analyst from KeyBanc maintains HNGE with a strong buy rating and raises their HNGE price target from $45.00 to $60.00, on Jul 14, 2025.
Jailendra Singh, a bottom 1% analyst from Truist Securities initiates coverage on HNGE with a strong buy rating and announces their HNGE price target of $48.00, on Jun 16, 2025.
You can dive deeper into what analysts are saying on the Hinge Health stock forecast page.
Over the last 12 months, executives and large shareholders at HNGE have sold more shares than they have bought.
Daniel Antonio Perez, CEO Co-Founder of HNGE, was the latest HNGE insider to buy. They bought $5,703.49 worth of HNGE stock on Aug 4, 2025.
Research more about who owns HNGE stock here.
No, Hinge Health doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two main types of orders:
Hit the Open Trade button and eToro will place your order.
If you want more help investing in stocks on eToro, watch the how to video below:
Now that you own some HNGE stock, you'll want to stay up-to-date on your investment.
Make a watchlist to see the latest developments about your HNGE stock.
To summarize, here are the 6 steps for buying Hinge Health stock:
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Hinge Health, add HNGE to your watchlist by clicking the button below.